Brief: VectivBio Announces Japan License Deal And Loan Facility Agreement, Providing Up To $117 Million To Fuel Company Through Key Catalysts
30/03/2022 13:52
March 30 (Reuters) - VectivBio Holding AG VECT.O :
* VECTIVBIO ANNOUNCES JAPAN LICENSE DEAL AND LOAN FACILITY
AGREEMENT, PROVIDING UP TO $117 MILLION TO FUEL THE COMPANY
THROUGH KEY CATALYSTS
* VECTIVBIO HOLDING - EXCLUSIVE LICENSE WITH ASAHI KASEI
PHARMA TO
DEVELOP AND COMMERCIALIZE APRAGLUTIDE IN JAPAN INCLUDES $30
MILLION UPFRONT CASH PAYMENT
Source text for Eikon: ID:nGNX1kvvBy
Further company coverage: VECT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VectivBio Holding AG
See all newsBrief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill